Mes publications
2022 Publications
-
Distribution of the positive added medical benefit according to the early access status and the potential public health interest – analysis of the french hta body opinions (has transparency committee)Élément de liste 1
ISPOR Europe 2022
-
Comparative analysis of the transparency committee opinions concerning the added medical benefit levels depending on the therapeutic areas: distribution of innovation and trend assessment for 2016-2021
ISPOR Europe 2022
2020 Publications
2019 Publications
-
Comparative analysis of the Transparency Committee opinions concerning the added medical benefit obtained by drugs available through the early access program vs other drugs in France
ISPOR 2019, Copenhagen, Denmark
-
Comparative analysis of the Transparency Committee opinions concerning the medical benefit obtained by drugs available in early access program vs other drugs in France
ISPOR 2019, Copenhagen, Denmark
-
Reimbursement and pricing times for drugs depending on the early access status in France (with or without an ATU)
ISPOR 2019, Copenhagen, Denmark
-
Comparison of early access programs for Orphan drugs in the EU-5 countries
ISPOR 2019, Copenhagen, Denmark
-
Innovative Gene and Cell therapies -Market Access and Reimbursement decisions in the EU-5 : availability or not, that is the question…Élément de liste 1
ISPOR 2019, Copenhagen, Denmark
-
Market Access, Pricing and Reimbursement processes for Orphan Drugs in the EU-5 countries : a comparative assessment
ISPOR 2019, Copenhagen, Denmark
-
Time to reimbursement for orphan drugs in EU5 in the last 3 years
ISPOR 2019, Copenhagen, Denmark
2018 Publications
-
The budget impact of global telemedicine solution in France
ISPOR 2018, Barcelona, Spain
-
Time to Market and Price comparison for Biosimilars drugs in EU5Élément de liste 1
ISPOR 2018, Barcelona, Spain
-
The budget impact of nicotinic substitute reimbursement
ISPOR 2018, Barcelona, Spain
-
Prices differences for Oncology drugs across the EU-5 countries: a comparative assessment
ISPOR 2018, Barcelona, Spain
-
Prices differences for Orphan drugs across the EU-5 countries : a comparative assessment
ISPOR 2018, Barcelona, Spain
-
Time to reimbursement for Oncology drugs in EU5
ISPOR 2018, Baltimore, MD, United-States
-
Time to reimbursement for orphan drugs in EU5
ISPOR 2018, Baltimore, MD, United-States